Robert Hammers | February 17, 2026 | Product Liability
GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro have become widely prescribed across the United States for managing diabetes and supporting weight loss. However, as their popularity has grown, scrutiny of their safety has increased.
In recent years, patients have filed lawsuits alleging that manufacturers failed to adequately warn about certain severe side effects, including serious gastrointestinal complications.
Some of these reported injuries have required emergency medical intervention and, in extreme cases, have resulted in permanent lifestyle changes. While litigation involving these drugs is ongoing, the claims have raised important questions about how GLP-1 medications affect the digestive system and what patients should know about potential risks.
What Are GLP-1s?
GLP-1s are a class of medications originally developed to help manage blood sugar levels in people with type 2 diabetes.
Common GLP-1 medications include:
- Semaglutide (Ozempic, Wegovy, Rybelsus)
- Liraglutide (Victoza, Saxenda)
- Dulaglutide (Trulicity)
- Tirzepatide (Mounjaro, Zepbound)
In addition to controlling blood sugar, these medications can reduce appetite and slow the rate at which food moves through the digestive tract. While this may support weight loss, it also plays a central role in the gastrointestinal injury claims raised in lawsuits involving GLP-1s.
By significantly slowing digestion, GLP-1 drugs may increase the risk of severe digestive complications in some patients, according to the allegations made in these cases.
Severe Gastrointestinal Complications Reported in GLP-1 Lawsuits
Many of the lawsuits involving Ozempic, Wegovy, and similar GLP-1s focus on serious gastrointestinal injuries that patients say developed during or after using the drugs.
The most commonly reported complications include:
- Intestinal obstruction, where the normal movement of food and waste through the intestines becomes blocked
- Gastroparesis (“stomach paralysis”), a condition in which the stomach slows or stops emptying food into the small intestine
- Ileus, a condition in which the bowel temporarily stops functioning
- Severe or prolonged constipation that does not respond to routine treatment
- Bowel perforation or colon rupture, sometimes occurring without obvious warning symptoms
- Other gastrointestinal complications, such as extreme vomiting leading to dehydration or hospitalization
- Sepsis, a life-threatening infection that can follow intestinal injury
Some patients allege that intestinal blockages progressed quietly, without clear early symptoms, until they became a medical emergency requiring urgent surgery. These claims form a central part of the ongoing litigation involving GLP-1 drugs.
How Severe Digestive Injuries Can Affect Daily Life
Serious gastrointestinal injuries can have lasting consequences that extend well beyond the initial hospitalization. Patients who experience complications such as bowel perforation or obstruction may face permanent changes that affect their independence and quality of life.
Long-term impacts may include chronic digestive dysfunction, difficulty eating or absorbing nutrients, and an increased risk of future infections. In some cases, these complications have resulted in the need for a permanent stoma, requiring ongoing medical care and lifestyle adjustments.
Many patients also report struggling with anxiety or depression, particularly when injuries result in permanent physical changes or limitations.
Other Side Effects Alleged in GLP-1 Lawsuits
Although severe gastrointestinal injuries are a primary focus of many lawsuits, patients have reported a range of other side effects associated with GLP-1 medications.
Allegations in these cases include:
- Gallbladder injuries, sometimes requiring surgical removal
- Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a condition involving reduced blood flow to the optic nerve that can result in partial or permanent vision loss
- Neurological complications, including cognitive or coordination issues
Not every patient experiences these effects, and manufacturers deny that the drugs are unsafe when used as directed. However, plaintiffs allege that the risks of severe outcomes were not adequately disclosed at the time they were prescribed the medication.
Why Are Patients Filing Lawsuits Over Ozempic and Similar GLP-1 Drugs?
Lawsuits over Ozempic, Wegovy, and other GLP-1s generally claim that drug manufacturers failed to provide sufficient warnings about the potential for severe gastrointestinal and other complications. These cases are typically brought as product liability claims, focusing on whether drug makers adequately disclosed known or foreseeable risks.
In response to growing litigation, product labels for some GLP-1 medications have been updated to include additional gastrointestinal warnings. Many of the lawsuits have been consolidated into federal multidistrict litigation, where common legal and scientific questions are being addressed.
These lawsuits do not allege that every patient will experience complications. Instead, they focus on whether certain serious risks were clearly communicated to patients and prescribing providers so that fully informed decisions could be made.
What to Do If You Experience Severe Symptoms While Taking a GLP-1 Medication
Anyone taking Ozempic, Wegovy, or another GLP-1 medication should seek immediate medical attention if they experience severe abdominal pain, persistent vomiting, extreme constipation, or other concerning symptoms.
Patients should not stop taking prescribed medication without first consulting a healthcare provider, as abrupt changes can pose additional risks. Keeping detailed records of symptoms, medical visits, and treatment can also be important if complications arise.
Contact the Atlanta Product Liability Lawyers at Hammers Car Accident & Personal Injury Lawyers for a Free Consultation
If you or a loved one experienced serious complications after taking Ozempic or another GLP-1 drug—especially injuries requiring hospitalization, surgery, or long-term medical care—it may be worth exploring your legal options.
A dedicated personal injury attorney can help evaluate whether your injuries may be connected to inadequate drug warnings and guide you through the next steps. While litigation involving GLP-1 medications is still evolving, patients who have suffered significant harm deserve answers and accountability.
Contact the Atlanta product liability attorneys at Hammers Car Accident & Personal Injury Lawyers for a free case evaluation to learn more.
We proudly serve clients throughout Fulton County and the greater Atlanta metro area in Georgia, with offices in Atlanta, Sandy Springs, Lawrenceville, Smyrna, Roswell, and Mableton.
Hammers Car Accident & Personal Injury Lawyers – Atlanta
201 Joseph E Lowery Blvd NW Suite 312, Atlanta, GA 30314
Open 24/7
(770) 900-9000
Hammers Car Accident & Personal Injury Lawyers – Sandy Springs
5555 Glenridge Con, Suite 975, Sandy Springs, GA 30342
Open 24/7
(678) 990-7024
Hammers Car Accident & Personal Injury Lawyers – Lawrenceville
265 Culver St S. Suite A. Lawrenceville, GA 30046
Open 24/7
(678) 626-5067
Hammers Car Accident & Personal Injury Lawyers – Mableton
5701 Mableton Pkwy SW Suite 108, Mableton, GA 30126
Open 24/7
(706) 480-5487
Hammers Car Accident & Personal Injury Lawyers – Smyrna
2400 Herodian Way Ste#220, Smyrna, GA 30080
Open 24/7
(678) 922-4497
Hammers Car Accident & Personal Injury Lawyers – Roswell
110 Mansell Cir #111, Roswell, GA 30075
Open 24/7
(678) 582-8466
About Robert M. Hammers Jr.
Robert M. Hammers, Jr. is the managing partner at Hammers Car Accident & Personal Injury Lawyers in Atlanta. Committed to justice, he represents individuals harmed by negligence, focusing on personal injury litigation.
With over 50 jury trials and $100 million in verdicts and settlements, Rob is known for his strategic thinking and dedication to achieving the best outcomes for his clients. He serves on the Executive Committee for the Georgia Trial Lawyers Association, the American Association for Justice Board of Governors, and the Plaintiff Leadership Committee in complex multi-district and toxic tort litigations, where he advocates for injured individuals and shapes legal strategies.
Robert is also recognized on Justia for his excellence in personal injury law, further highlighting his reputation and commitment to client advocacy.
